Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-26

Clinical Trial Update: Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 2/Phase 3 study evaluating chidamide in combination with antiretroviral therapy (ART) to reactivate the latent HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chidamide (chidamide)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Chronic HIV Infections | Phase 2, Phase 3 | Status: UNKNOWN